Bill Sheridan

Track

Insider profile

Currently holds a position at BioCryst Pharmaceuticals Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 36% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President, Chief Medical Officer BioCryst Pharmaceuticals Inc July 1, 2008 -
Bill Sheridan's trades of BioCryst Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-03-14 2022-03-10
S Sale
14,572 +22.2%
30.80
US$3,310,345 		14,572 +22.2% 30.80 US$3,310,345
2022-03-14 2022-03-10
S Sale
61,275 +16.6%
205.31
US$2,298,214 		61,275 +16.6% 205.31 US$2,298,214
2021-06-01 2021-05-28
PlS Planned sale
77,091 -0.7%
498.21
US$2,087,199 		77,091 -0.7% 498.21 US$2,087,199
2021-06-01 2021-05-27
PlS Planned sale
71,759 -83.2%
15.00
US$1,076,385 		71,759 -83.2% 15.00 US$1,076,385
2021-02-24 2021-02-22
PlS Planned sale
41,250 -78.2%
11.57
US$477,262 		41,250 -78.2% 11.57 US$477,262